Evidence map›Paper›PMID 29744431›Full record

ArticleBioactive materials2017

Analysis of the

Mike Barbeck, Tiziano Serra, Patrick Booms, Sanja Stojanovic, Stevo Najman, Elisabeth Engel, Robert Sader, Charles James Kirkpatrick, Melba Navarro, Shahram Ghanaati

Abstract read
In one paragraph

Article in Bioactive materials, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Mike BarbeckPrivate Office, Berlin, Germany.
Tiziano SerraInstitute for Bioengineering of Catalonia (IBEC), Biomaterials for Regenerative Medicine, Barcelona, Spain.
Patrick BoomsClinic of Oro-Maxillofacial and Plastic Surgery, FORM-Lab, Goethe University Frankfurt, Frankfurt, Germany.
Sanja StojanovicUniversity of Niš, Faculty of Medicine, Department for Cell and Tissue Engineering, Institute of Biology and Human Genetics, Niš, Serbia.
Stevo NajmanUniversity of Niš, Faculty of Medicine, Department for Cell and Tissue Engineering, Institute of Biology and Human Genetics, Niš, Serbia.
Elisabeth EngelInstitute for Bioengineering of Catalonia (IBEC), Biomaterials for Regenerative Medicine, Barcelona, Spain.
Robert SaderClinic of Oro-Maxillofacial and Plastic Surgery, FORM-Lab, Goethe University Frankfurt, Frankfurt, Germany.
Charles James KirkpatrickClinic of Oro-Maxillofacial and Plastic Surgery, FORM-Lab, Goethe University Frankfurt, Frankfurt, Germany.
Melba NavarroInstitute for Bioengineering of Catalonia (IBEC), Biomaterials for Regenerative Medicine, Barcelona, Spain.
Shahram GhanaatiClinic of Oro-Maxillofacial and Plastic Surgery, FORM-Lab, Goethe University Frankfurt, Frankfurt, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of the present study was the

Indexed as

Bi-layer scaffoldBioactive glassBone substituteCalcium phosphate glassMultinucleated giant cellsPolylactic acid (PLA)Vascularization

Identifiers

PMID29744431
PMCPMC5935508

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.